ÂÜÀòÂÒÂ×

Mathew Bazley was appointed General Counsel of Axovant in October 2018. Mr. Bazley was previously General Counsel of The Medicines Company’s infectious disease business and Deputy General Counsel of the company as a whole. Prior to The Medicines Company, he was Assistant General Counsel of Savient Pharmaceuticals. Prior to Savient, he practiced law in the New York office of Skadden, Arps, Slate, Meagher & Flom. He began his career as an attorney with the U.S. Securities & Exchange Commission in Washington D.C. He received his J.D. and M.B.A. from Emory University and a B.S.B.A. from Georgetown University.